Skip to main content
Log in

Hämodynamische Wirkungen des Betablockers Nebivolol

  • Leserfragen
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Levick JR (1998) Die Steuerung des Schlagvolumens und des Herzminutenvolumens. In: Levick JR (Hrsg) Physiologie des Herz-Kreislauf-Systems. Barth, Heidelberg Leipzig, S 87–120

  2. Broeders MAW, Doevedans PA, Bekkers BCAM, Bronsaer R, Gorsel E v (2000) Nebivolol: A third-generation β-blocker that augments vascular nitric oxide release. Circulation 102: 677–684

    Google Scholar 

  3. Wisenbaugh T, Katz I, Davis J et al. (1993) Long-term (3-month) effects of a new beta-blocker (Nebivolol) on cardiac performance in dilated cardiomyopathy. J Am Coll Cardiol 21: 1094–1100

    Google Scholar 

  4. Rousseau MF, Chapelle F, Van Eyll C, Stolteru L, Hager D, Van Nueten L, Pouleur H (1996) Medium-term effects of beta-blockade on left ventricular mechanics: A double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction. J Card Fail 2: 15–23

    Google Scholar 

  5. Böhm M, Maack C (2000) Treatment of heart failure with beta-blockers. Mechanisms and results. Basic Res Cardiol 95 (Suppl): I15–I24

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. Erdmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenkranz, S., Erdmann, E. Hämodynamische Wirkungen des Betablockers Nebivolol. Internist 44, 481–482 (2003). https://doi.org/10.1007/s00108-003-0874-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-003-0874-z

Navigation